Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Advaxis Appoints Tom Ridge, America’s First Secretary of Homeland Security and 43rd Governor of Pennsylvania, to Board of Directors

8/18/2015

0 Comments

 
Princeton, NJ - Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, announced the appointment of The Honorable Tom Ridge, the first Secretary of the U.S. Department of Homeland Security and 43rd Governor of Pennsylvania, to the Company’s Board of Directors. “We are very excited to have Governor Ridge join Advaxis’s Board of Directors,” said Daniel J. O’Connor, president and Chief Executive Officer of Advaxis.

Read More
0 Comments

NJ’s Life Sciences Industry Makes its Mark at 2015 BIO International

8/9/2015

0 Comments

 
Trenton, NJ - According to New Jersey Business magazine, "New Jersey pulled out all the stops in attracting the international biotech community at the recent 2015 BIO International Convention in Philadelphia. The event drew 15,858 industry leaders from 69 countries and 47 states, and the New Jersey delegation spent the three-day event in June discussing the many benefits of growing and attracting a business to the Garden State for this global audience."

Read More
0 Comments

NJ Lab Equipment Testing Company Welcomes GE Product Line

8/9/2015

0 Comments

 
Bound Brook, NJ - A New Jersey company that specializes in monitoring and maintaining the accuracy of laboratory equipment has expanded its role even further by adding a well known innovator, General Electric, as a provider among its array of high-tech equipment and services. Baseline Service, LLC, headquartered in Bound Brook, NJ, recently announced that it is a distributor for GE's Measurement & Control Division.

Read More
0 Comments

Catalent Biologics announces new advisory board

8/9/2015

0 Comments

 
Somerset, NJ - According to Emily Bader of NJBiz, "Catalent announced it has formed an advisory board to structure the development of its biologics business. The Somerset-based provider of advanced technologies said in a news release that the founding members of its advisory board are Carolyn Bertozzi, Barry Buckland, Michael Buckley, Daniel R. Marshak and Edward R. Robinson.

Read More
0 Comments

Merck buys Israeli biopharma firm for $95M

8/4/2015

0 Comments

 
Kenilworth, NJ - According to Eric Strauss of NJBiz, "Merck is acquiring an Israeli biopharmaceutical company for $95 million in cash, the drugmaker announced Tuesday. The Kenilworth-based company’s deal for cCAM Biotherapeutics, which is focused on cancer immunotherapies, could potentially include up to $510 million in milestone payments, it said."

Read More
0 Comments

Internet of Medical Things Addresses CyberSecurity Issues Facing Pharmas and Device Developers 

8/4/2015

1 Comment

 
Tinton Falls, NJ - At the Internet of Medical Things speakers from Johnson & Johnson, the FDA, Sage Bionetworks, and WAM Consulting Group presented their perspectives on issues key to developing safeguards for drug development data, patient records, and medical devices. Dr. Suzanne Schwartz, the FDA’s Director for Emergency Preparedness, addressed the agency’s approach to building internal communications and public­ private partnerships to enhance cybersecurity throughout the healthcare system. While it’s not always easy to find a “front door” for collaborating with the FDA, she mentioned National Healthcare & Public Health Critical Infrastructure Protection (http://www.nhisac.org/). 

Read More
1 Comment

NJ Resources Support Serial Entrepreneur David Fischell’s  Mission to Create Life-Saving Medical Devices

8/4/2015

0 Comments

 
Trenton, NJ - The New Jersey Economic Development Authority (EDA) continues its series highlighting how entrepreneurs and investors are helping to build New Jersey’s technology ecosystem. Serial entrepreneur Dr. David Fischell, of Fair Haven, has founded and led more than a dozen medical device companies to success in the last 20 years. To Fischell, developing medical devices is a family affair. David, along with his father Dr. Robert Fischell, a physicist, and his brother Dr. Tim Fischell, a cardiologist, started New Providence-based Svelte Medical Systems in 2007.

Read More
0 Comments

Educated Workforce Helps Attract Scientist-Turned-Entrepreneur in NJ

7/27/2015

0 Comments

 
Trenton, NJ - The New Jersey Economic Development Authority (EDA) continues its series highlighting how entrepreneurs and investors are helping to build New Jersey’s technology ecosystem: In 1999, scientist-turned-entrepreneur Navneet Puri earned his PhD in Pharmaceutical Sciences from Rutgers University and went on to found InnoPharma, Inc. in Piscataway just a few years later. The research and development pharmaceutical company, focused on developing complex generic and innovative specialty products in injectable and ophthalmic dosage forms,   was ultimately acquired by pharmaceutical giant Pfizer last year. Under Puri’s leadership, InnoPharma had more than 30 products in various stages of development, including 10 generic products that had received Food and Drug Administration approval.

Read More
0 Comments

Celgene to Acquire Receptos

7/20/2015

0 Comments

 
Summit, NJ – According to New Jersey Business Magazine, “Celgene Corporation and San Diego-based Receptos, Inc. sign a definitive agreement in which Celgene has agreed to acquire Receptos. Under the terms of the merger agreement, Celgene will pay $232.00 per share in cash, or a total of approximately $7.2 billion, net of cash acquired.”

Read More
0 Comments

Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport

7/20/2015

0 Comments

 
Basking Ridge, NJ – According to New Jersey Business Magazine, Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) for Dysport® (abobotulinumtoxinA) for the treatment of upper limb spasticity (ULS) in adult patients to decrease the severity of increased muscle tone in elbow flexors, wrist flexors and finger flexors. Clinical improvement may be expected one week after administration of Dysport®.”

Read More
0 Comments

Novartis gets early approval for heart failure drug, a potential blockbuster

7/13/2015

0 Comments

 
Trenton, NJ - According to Tom Bergeron of NJBiz, "Novartis officials were hoping the FDA would give approval for what they hope will be a blockbuster drug for heart failure by the end of the summer. On Tuesday, they got even better news. The U.S. Food & Drug Administration approved Entresto (formerly called LCZ696) six weeks ahead of the priority review action date."

Read More
0 Comments

Biopharma company adds execs in advance of product license request

7/7/2015

0 Comments

 
Ramsey, NJ - According to Eric Strauss of NJBiz, "Ramsey-based biopharmaceutical company ADMA Biologics Inc. has added a senior vice president and two other executives to its commercialization team as it prepares to seek a license for its top immune deficiency disease product."

Read More
0 Comments

NJEDA Accepting Applications for Executives-in-Residence Program

7/7/2015

0 Comments

 
Trenton, NJ - According to NJ Business magazine, "On June 30, the NJ Economic Development Authority (EDA) announced it is accepting applications for a second group of Executives-in-Residence at the Commercialization Center for Innovative Technologies (CCIT). The program, a joint effort organized by the EDA and BioNJ, links emerging biotechnology companies with experienced mentors to help take their businesses to the next level. Applications are open to New Jersey executives with experience in business development, health economics, regulation and other areas. More information can be found here.

0 Comments

Celgene Announces Agreement to Purchase NJ Research and Office Facility

7/7/2015

0 Comments

 
Summit, NJ - Celgene Corporation announced that it has entered into an agreement to purchase the Merck & Co., Inc.  research and office facility located at 556 Morris Avenue in Summit, New Jersey.  Pending the completion of due diligence, closing is planned for September.  Financial terms of the agreement are not being disclosed.  

Read More
0 Comments

Lt. Governor Welcomes Life Science Companies to Business Roundtable

6/29/2015

0 Comments

 
Newark, NJ - Highlighting New Jersey’s leadership as a home for innovation and the “Medicine Chest of the World,” Lt. Governor Kim Guadagno addressed the New Jersey Performing Arts Center’s (NJPAC) Business Partners “Life Sciences as an Engine of Innovation” Roundtable, presented in association with the HealthCare Institute of New Jersey (HINJ).

Read More
0 Comments
<<Previous
    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Powered by Create your own unique website with customizable templates.